Business description: Becton, Dickinson and Company

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows:

- medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.;

- interventional medical equipment (23.9%): surgical instruments, urological care products, etc.;

- diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc.

Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).

Number of employees: 72,000

Sales by Activity: Becton, Dickinson and Company

Fiscal Period: September 2021 (USD) 2022 (USD) 2023 (USD) 2024 (USD) 2025 (USD)

BD Medical (Excl. of BD Interventional)

9.48B 8.84B 9.5B 10.07B 11.46B

BD Interventional

4.24B 4.46B 4.74B 4.98B 5.22B

BD Life Sciences

6.53B 5.56B 5.13B 5.19B 5.17B

Other

- - - -67M -

Geographical breakdown of sales: Becton, Dickinson and Company

Fiscal Period: September 2021 (USD) 2022 (USD) 2023 (USD) 2024 (USD) 2025 (USD)

United States

10.97B 10.72B 11.11B 11.66B 12.79B

Europe, The Middle East and Africa (EMEA)

4.75B 4.04B 4.24B 4.4B 4.73B

Greater Asia

3.27B 3.05B 2.91B 2.91B 3.09B

Other

1.26B 1.06B 1.1B 1.21B 1.23B

Executive Committee: Becton, Dickinson and Company

Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Chief Tech/Sci/R&D Officer 56 2023-12-03
Chief Tech/Sci/R&D Officer - 2021-11-28

Composition of the Board of Directors: Becton, Dickinson and Company

Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Director/Board Member 65 2016-09-22
Director/Board Member 68 2017-12-28
Director/Board Member 61 2018-08-09
Director/Board Member 63 2021-10-20
Director/Board Member 64 2022-02-27
Director/Board Member 66 2023-07-23
Director/Board Member 65 2025-03-25

Shareholders: Becton, Dickinson and Company

NameStocks%Valuation
BlackRock Advisors LLC
6.961 %
19,180,606 6.961 % 2 822 M €
Vanguard Capital Management LLC
6.711 %
18,490,610 6.711 % 2 720 M €
Vanguard Portfolio Management LLC
5.559 %
15,317,242 5.559 % 2 253 M €
5.017 %
13,822,808 5.017 % 2 034 M €
First Eagle Investment Management LLC
4.329 %
11,928,111 4.329 % 1 755 M €
NameStocks%Valuation
BRAM - Bradesco Asset Management SA DTVM
0.000004 %
50 0.000004 % 1 412 €

Company details: Becton, Dickinson and Company

Becton, Dickinson & Co.

1 Becton Drive

07417-1880, Franklin Lakes

+201 847 6800

http://www.bd.com
address Becton, Dickinson and Company(BOX)

Group companies: Becton, Dickinson and Company

NameCategory and Sector
Medical Specialties
Information Technology Services
Finance/Rental/Leasing
Medical Specialties
Becton Dickinson Luxembourg Finance SARL

Other Medical Equipment, Supplies & Distribution

Change 5-day change 1-year change 3-year change Capi.($)
-0.50%-1.54%-28.85%-12.09% 164B
+1.80%+0.82%-6.73%-4.23% 107B
+0.32%+2.34%+2.79%+59.04% 59.04B
+1.74%-0.66%+39.82%+55.19% 51.72B
+0.47%-4.98% - - 34.7B
+2.66%+5.21%-10.09%-43.92% 28.93B
-1.10%-3.29%+55.70%-7.77% 24.99B
0.00%-1.01%-5.28%-4.72% 21.05B
+2.06%+1.72%-10.01%-18.97% 20.39B
Average +0.83%-0.49%+4.67%+2.82% 56.86B
Weighted average by Cap. +0.64%-0.60%-5.10%+4.10%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
151.94USD
Average target price
176.92USD
Spread / Average Target
+16.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BDX Stock
  4. BOX Stock
  5. Company Becton, Dickinson and Company